Biogen (BIIB) EPS (Basic) (2009 - 2026)

Biogen has reported EPS (Basic) for 18 years, with the latest figure at $0.66 in Q2 2026.

• On a quarterly basis, EPS (Basic) fell 84.77% year-over-year to $0.66 in Q2 2026; TTM through Jun 2026 was $5.65, a 45.91% decrease from a year earlier, with the FY2025 full-year figure at $8.83, down 21.27% from the prior year.
• EPS (Basic) was $0.66 for Q2 2026 at Biogen, down from $2.17 in the prior quarter.
• The five-year high for EPS (Basic) was $7.86 in Q3 2022, with the low at -$0.47 in Q3 2023.
• Average EPS (Basic) over 5 years is $2.85, with a median of $2.68 recorded in 2023.
• The sharpest annual moves came in 2022 and 2025: EPS (Basic) jumped 1576.1% in 2022, then tumbled 118.22% in 2025.
• Over 5 years, EPS (Basic) stood at $3.78 in 2022, then tumbled by 54.52% to $1.72 in 2023, then rose by 6.49% to $1.83 in 2024, then sank by 118.22% to -$0.33 in 2025, then soared by 297.77% to $0.66 in 2026.
• The last three EPS (Basic) figures came in at $0.66 (Q2 2026), $2.17 (Q1 2026), and -$0.33 (Q4 2025), per Business Quant data.